Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3727737
Max Phase: Preclinical
Molecular Formula: C14H24O2
Molecular Weight: 224.34
Molecule Type: Small molecule
Associated Items:
ID: ALA3727737
Max Phase: Preclinical
Molecular Formula: C14H24O2
Molecular Weight: 224.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C(OCC)C1C(C)(C)CC(=O)CC1(C)C
Standard InChI: InChI=1S/C14H24O2/c1-7-16-10(2)12-13(3,4)8-11(15)9-14(12,5)6/h12H,2,7-9H2,1,3-6H3
Standard InChI Key: YLNYLLVKHRZLGO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 224.34 | Molecular Weight (Monoisotopic): 224.1776 | AlogP: 3.57 | #Rotatable Bonds: 3 |
Polar Surface Area: 26.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.81 | CX LogD: 2.81 |
Aromatic Rings: 0 | Heavy Atoms: 16 | QED Weighted: 0.69 | Np Likeness Score: 1.01 |
1. (2013) Agent for inhibiting odor of pyrazine derivatives, |
Source(1):